Clinical Trial Detail

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

NCT ID	NCT06085729
Title	Phase I/II Study of PEGylated Arginine Deiminase (ADI-PEG20) With Carboplatin and Cabazitaxel in Men With Aggressive Variant Prostate Cancers (AVPC)
Recruitment	Recruiting
Gender	male
Phase	Phase Ib/II
Variant Requirements	Yes
Sponsors	M.D. Anderson Cancer Center
Indications	prostate small cell carcinoma prostate carcinoma
Therapies	ADI-PEG 20 + Cabazitaxel + Carboplatin
Age Groups:	adult \| senior
Covered Countries	USA